Account Executive, Crisis Communications at Orchestra Bio

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Public Relations, CommunicationsIndustries

Requirements

2-3 years of relevant experience in strategic communications in a PR agency or media outlet, or politics, government or advocacy
Ability to communicate clearly and effectively, both orally and in writing
Ability to handle multiple assignments at once, work quickly and meet deadlines in a fast-paced environment
Strong attention to detail and organizational skills
Ability to work with a team to meet group objectives

Responsibilities

Implement strategy, creative brainstorming and campaign planning for multiple high-profile accounts
Manage media monitoring and rapid response for clients
Write and edit persuasive external and internal documents including vetting reports, research memos, and fact sheets
Oversee day-to-day communications with clients, including staffing weekly calls, and analyzing press coverage and writing event recaps
Manage work streams across multiple accounts

Skills

Crisis Communications

Media Strategy

Stakeholder Communications

Strategic Communications

Advocacy

Orchestra Bio

Facilitates biotech collaborations through software

About Orchestra Bio

Orchestra.bio improves the biotech industry by facilitating partnerships among biotech firms, CROs, CDMOs, and biopharmaceutical companies. Their software platform addresses the challenges of collaboration, making it easier and safer for organizations to work together. This focus on enhancing collaboration sets them apart from competitors, as they aim to streamline the process of bringing biotech products to market. The goal of Orchestra.bio is to increase operational efficiency and speed up the development of life-saving therapeutics and other biotech innovations.

San Francisco, CaliforniaHeadquarters

2022Year Founded

VENTURE_UNKNOWNCompany Stage

Enterprise Software, BiotechnologyIndustries

11-50Employees

Risks

Emerging biotech software platforms could erode Orchestra.bio's market share.

Rapid AI advancements may outpace Orchestra.bio's current software capabilities.

Data privacy concerns could impact Orchestra.bio's international operations.

Differentiation

Orchestra.bio focuses on enhancing biotech collaborations through innovative software solutions.

The company addresses operational challenges in cross-organizational biotech collaborations.

Orchestra.bio's platform streamlines collaboration, reducing risks and operational burdens.

Upsides

Increased demand for AI-driven drug discovery boosts need for collaboration software.

Decentralized clinical trials require robust software for managing complex collaborations.

Biopharma outsourcing to CROs and CDMOs increases demand for advanced collaboration platforms.

Land your dream remote job 3x faster with AI

Try Jobo Free